| Financial Year |
March 31 2023 |
| Monetary Funds |
618,620,295.67 |
| Held-for-trading Financial Assets |
60,181,050.80 |
| Notes Receivable |
-- |
| Accounts Receivable |
120,533,001.88 |
| Advances to Suppliers |
16,230,744.10 |
| Other Receivables |
1,805,195.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
186,921,339.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,204,758.20 |
| Total Current Assets |
1,007,496,385.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
382,614.30 |
| Fixed Assetes |
556,635,225.61 |
| Under-construction Projects |
47,083,955.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
154,755,189.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,783,146.74 |
| Deferred Income Tax Assets |
31,967,925.80 |
| Other Non-Current Assets |
20,812,060.50 |
| Sub-Total of Non-Current Assets |
861,109,088.89 |
| Total Assets |
1,868,605,474.86 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
94,898,000.00 |
| Accounts Payable |
202,823,176.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,413,443.54 |
| Taxes Payable |
38,295,130.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,377,577.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
52,906,393.96 |
| Sub-Total of Current Liabilities |
477,879,892.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
150,879.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,020,563.26 |
| Total Liabilities |
497,900,455.53 |
| Paid-In Capital(Or Share Stock) |
450,000,000.00 |
| Capital Surplus |
341,710,686.10 |
| Surplus Reserve |
46,115,275.59 |
| LESS:Treasury Stock |
59,738,262.04 |
| Undistributed Profits |
608,629,819.68 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,370,705,019.33 |
| Owner's Equity（Stockholder's Equity） |
1,370,705,019.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,868,605,474.86 |
